These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 17609457)

  • 1. Evaluation of cerebral microemboli during radiofrequency ablation of lung tumors in a canine model with use of impedance-controlled devices.
    Ahrar K; Stafford RJ; Tinkey PT; Borne AT; Stephens LC; Wallace MJ; Wright KC
    J Vasc Interv Radiol; 2007 Jul; 18(7):929-35. PubMed ID: 17609457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of cerebral microembolism during percutaneous radiofrequency ablation of lung tumors using diffusion-weighted imaging.
    Yamamoto A; Matsuoka T; Toyoshima M; Okuma T; Oyama Y; Hamuro M; Nakayama K; Inoue K; Nakamura K; Inoue Y
    AJR Am J Roentgenol; 2004 Dec; 183(6):1785-9. PubMed ID: 15547230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral microembolization during radiofrequency ablation of lung malignancies.
    Rose SC; Fotoohi M; Levin DL; Harrell JH
    J Vasc Interv Radiol; 2002 Oct; 13(10):1051-4. PubMed ID: 12397129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral microembolisation during radiofrequency ablation of lung tumours: detection by carotid duplex ultrasound.
    Tanigawa N; Kariya S; Kojima H; Komemushi A; Shomura Y; Ikeda K; Omura N; Tokuda T; Maehara M; Terada J; Sawada S
    Br J Radiol; 2009 Mar; 82(975):249-53. PubMed ID: 19029223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Image-guided radiofrequency ablation of hepatocellular carcinoma (HCC): is MR guidance more effective than CT guidance?
    Clasen S; Rempp H; Hoffmann R; Graf H; Pereira PL; Claussen CD
    Eur J Radiol; 2014 Jan; 83(1):111-6. PubMed ID: 24161781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thoracic tumors treated with CT-guided radiofrequency ablation: initial experience.
    Yasui K; Kanazawa S; Sano Y; Fujiwara T; Kagawa S; Mimura H; Dendo S; Mukai T; Fujiwara H; Iguchi T; Hyodo T; Shimizu N; Tanaka N; Hiraki Y
    Radiology; 2004 Jun; 231(3):850-7. PubMed ID: 15105453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microembolism and catheter ablation II: effects of cerebral microemboli injection in a canine model.
    Haines DE; Stewart MT; Barka ND; Kirchhof N; Lentz LR; Reinking NM; Urban JF; Halimi F; Deneke T; Kanal E
    Circ Arrhythm Electrophysiol; 2013 Feb; 6(1):23-30. PubMed ID: 23275248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiofrequency ablation of lung metastases close to large vessels during vascular occlusion: preliminary experience.
    de Baere T; Robinson JM; Rao P; Teriitehau C; Deschamps F
    J Vasc Interv Radiol; 2011 Jun; 22(6):749-54. PubMed ID: 21616429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Left Atrial Ablation Process and Strategy on Microemboli Formation During Irrigated Radiofrequency Catheter Ablation in an In Vivo Model.
    Takami M; Lehmann HI; Parker KD; Welker KM; Johnson SB; Packer DL
    Circ Arrhythm Electrophysiol; 2016 Jan; 9(1):e003226. PubMed ID: 26763224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiofrequency ablation of thoracic lesions: part 1, experiments in the normal porcine thorax.
    Morrison PR; vanSonnenberg E; Shankar S; Godleski J; Silverman SG; Tuncali K; Jaklitsch MT; Jolesz FA
    AJR Am J Roentgenol; 2005 Feb; 184(2):375-80. PubMed ID: 15671349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiofrequency ablation of thoracic lesions: part 2, initial clinical experience--technical and multidisciplinary considerations in 30 patients.
    VanSonnenberg E; Shankar S; Morrison PR; Nair RT; Silverman SG; Jaklitsch MT; Liu F; Cheung L; Tuncali K; Skarin AT; Sugarbaker DJ
    AJR Am J Roentgenol; 2005 Feb; 184(2):381-90. PubMed ID: 15671350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous radiofrequency ablation for lung tumors beneath the rib under CT fluoroscopic guidance with gantry tilt.
    Suzuki T; Yamagami T; Tanaka O; Yoshimatsu R; Miura H; Nishimura T
    Acta Radiol; 2010 May; 51(4):389-95. PubMed ID: 20380601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: prospective evaluation.
    de Baère T; Palussière J; Aupérin A; Hakime A; Abdel-Rehim M; Kind M; Dromain C; Ravaud A; Tebboune N; Boige V; Malka D; Lafont C; Ducreux M
    Radiology; 2006 Aug; 240(2):587-96. PubMed ID: 16864679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unresectable pulmonary malignancies: CT-guided percutaneous radiofrequency ablation--preliminary results.
    Suh RD; Wallace AB; Sheehan RE; Heinze SB; Goldin JG
    Radiology; 2003 Dec; 229(3):821-9. PubMed ID: 14657317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Needle-based ablation of renal parenchyma using microwave, cryoablation, impedance- and temperature-based monopolar and bipolar radiofrequency, and liquid and gel chemoablation: laboratory studies and review of the literature.
    Rehman J; Landman J; Lee D; Venkatesh R; Bostwick DG; Sundaram C; Clayman RV
    J Endourol; 2004 Feb; 18(1):83-104. PubMed ID: 15006061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for occurrence of local tumor progression after percutaneous radiofrequency ablation for lung neoplasms.
    Yamagami T; Kato T; Hirota T; Yoshimatsu R; Matsumoto T; Shimada J; Nishimura T
    Diagn Interv Radiol; 2007 Dec; 13(4):199-203. PubMed ID: 18092293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency and risk factors of various complications after computed tomography-guided radiofrequency ablation of lung tumors.
    Okuma T; Matsuoka T; Yamamoto A; Oyama Y; Toyoshima M; Nakamura K; Inoue Y
    Cardiovasc Intervent Radiol; 2008; 31(1):122-30. PubMed ID: 17985181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CT-guided radiofrequency ablation in the palliative treatment of recurrent advanced head and neck malignancies.
    Brook AL; Gold MM; Miller TS; Gold T; Owen RP; Sanchez LS; Farinhas JM; Shifteh K; Bello JA
    J Vasc Interv Radiol; 2008 May; 19(5):725-35. PubMed ID: 18440462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance guidance for radiofrequency ablation of liver tumors.
    Clasen S; Pereira PL
    J Magn Reson Imaging; 2008 Feb; 27(2):421-33. PubMed ID: 18219677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung cancer and radiofrequency ablation.
    Rose SC; Thistlethwaite PA; Sewell PE; Vance RB
    J Vasc Interv Radiol; 2006 Jun; 17(6):927-51; quiz 951. PubMed ID: 16778226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.